Shenzhen Salubris Pharmaceuticals Co., Ltd. (SHE:002294)
China flag China · Delayed Price · Currency is CNY
53.09
-1.59 (-2.91%)
Apr 28, 2026, 3:04 PM CST

SHE:002294 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
1,080968.431,1251,3222,6703,236
Short-Term Investments
-1,433988.85695.51531.58-
Trading Asset Securities
745.87688.98733.86186.06328.3660
Cash & Short-Term Investments
1,8263,0912,8482,2043,5303,296
Cash Growth
-32.50%8.52%29.25%-37.58%7.12%205.25%
Accounts Receivable
932.67850.55565.87545.38557.72474.03
Other Receivables
26.9430.8723.8521.0123.4155.48
Receivables
959.61881.42589.72566.39581.12629.51
Inventory
561.5548.19506.76490.86543.53420.45
Other Current Assets
954.0962.5380.0252.4356.3658
Total Current Assets
4,3014,5834,0253,3134,7114,404
Property, Plant & Equipment
1,5471,5321,4301,4571,5061,638
Long-Term Investments
508.06907.011,4921,701963.07854.48
Goodwill
219.49219.4910.9110.9160.5387.14
Other Intangible Assets
1,3501,4111,3351,318965.461,048
Long-Term Deferred Tax Assets
217.91215.64151.2487.488.4282.01
Long-Term Deferred Charges
2,1481,9961,5971,4161,3441,047
Other Long-Term Assets
1,114433.8424.7793.31116.6483.09
Total Assets
11,40511,29810,4669,3979,7559,244
Accounts Payable
184.54184.79126.09156.01219.65187.67
Accrued Expenses
173.93906.58716.68491.34558.35487.02
Short-Term Debt
152.22263.3412040177.1963
Current Portion of Leases
-5.869.710.9311.466.99
Current Income Taxes Payable
100.7125.967.1510.4928.9237.2
Current Unearned Revenue
49.1748.9439.3529.5542.6697.99
Other Current Liabilities
1,181578.569476.77565.4132.98
Total Current Liabilities
1,8422,0141,113815.081,6041,013
Long-Term Debt
68.6-----
Long-Term Leases
19.3920.984.1812.5419.589.11
Long-Term Unearned Revenue
146.8149.12142.0484.1198.5393.71
Long-Term Deferred Tax Liabilities
31.2632.1620.9713.0427.18-
Other Long-Term Liabilities
27.5427.54433.14416.4729.6482.57
Total Liabilities
2,1352,2441,7131,3411,7791,198
Common Stock
1,1151,1151,1151,1151,1151,115
Additional Paid-In Capital
2,0842,0811,9281,9001,8661,930
Retained Earnings
5,9465,7205,6205,5645,5295,330
Treasury Stock
----602.16-602.16-327.86
Comprehensive Income & Other
3.9916.8549.342.2233.24-13.41
Total Common Equity
9,1488,9338,7128,0197,9418,034
Minority Interest
121.69120.8440.1736.4335.8111.91
Shareholders' Equity
9,2709,0548,7528,0557,9778,046
Total Liabilities & Equity
11,40511,29810,4669,3979,7559,244
Total Debt
240.21290.19133.8863.47208.2379.1
Net Cash (Debt)
1,5862,8012,7142,1403,3223,217
Net Cash Growth
-37.86%3.18%26.83%-35.58%3.28%366.56%
Net Cash Per Share
1.412.492.441.923.023.01
Filing Date Shares Outstanding
1,1151,1151,1151,0911,0911,103
Total Common Shares Outstanding
1,1151,1151,1151,0911,0911,103
Working Capital
2,4602,5692,9122,4983,1083,391
Book Value Per Share
8.218.017.817.357.287.29
Tangible Book Value
7,5797,3037,3666,6906,9156,898
Tangible Book Value Per Share
6.806.556.616.136.346.26
Buildings
-1,2661,2221,2181,2081,218
Machinery
-1,3211,2581,2031,1381,109
Construction In Progress
-173.3262.3334.3537.694.13
Source: S&P Global Market Intelligence. Standard template. Financial Sources.